Shin Nippon Biomedical Laboratories

Chuo, Japan Founded: 2018 • Age: 8 yrs
Delivers comprehensive solutions for nasal drug delivery systems in the pharmaceutical industry.

About Shin Nippon Biomedical Laboratories

Shin Nippon Biomedical Laboratories is a company based in Chuo (Japan) founded in 2018. It operates as a B2B. Shin Nippon Biomedical Laboratories has completed 1 acquisition, including Satsuma Pharmaceuticals. Shin Nippon Biomedical Laboratories operates in a competitive market with competitors including MannKind Corp, OptiNose, Impel NeuroPharma, Alexza and Qnovia, among others.

  • Headquarter Chuo, Japan
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Investments & Acquisitions
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Shin Nippon Biomedical Laboratories

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investments & Acquisitions by Shin Nippon Biomedical Laboratories

Shin Nippon Biomedical Laboratories has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Satsuma Pharmaceuticals. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Therapeutics for migraine treatment are developed using nasal delivery.
2016
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Shin Nippon Biomedical Laboratories

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Shin Nippon Biomedical Laboratories Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Shin Nippon Biomedical Laboratories

Shin Nippon Biomedical Laboratories operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MannKind Corp, OptiNose, Impel NeuroPharma, Alexza and Qnovia, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Developer of small-molecule drugs
domain founded_year HQ Location
Developer of smart devices for nasal drug delivery
domain founded_year HQ Location
Intranasal delivery technology for CNS diseases is developed.
domain founded_year HQ Location
Developer of products for the treatment of acute and intermittent conditions
domain founded_year HQ Location
Inhaled drug delivery devices are developed for pharmaceuticals.
domain founded_year HQ Location
Inhalation devices for medical applications are developed by Iconovo.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Shin Nippon Biomedical Laboratories

Frequently Asked Questions about Shin Nippon Biomedical Laboratories

When was Shin Nippon Biomedical Laboratories founded?

Shin Nippon Biomedical Laboratories was founded in 2018.

Where is Shin Nippon Biomedical Laboratories located?

Shin Nippon Biomedical Laboratories is headquartered in Chuo, Japan. It is registered at Chuo, Yamanashi Prefecture, Japan.

What does Shin Nippon Biomedical Laboratories do?

Shin Nippon Biomedical Laboratories, based in Chuo, focuses on providing healthcare solutions, producing pharmaceutical products, drug delivery systems, and nasal solutions. Delivers comprehensive solutions for nasal drug delivery systems in the pharmaceutical industry. The company prioritizes operational excellence, innovation, and customer-centric approaches for success.

Who are the top competitors of Shin Nippon Biomedical Laboratories?

Shin Nippon Biomedical Laboratories's top competitors include MannKind Corp, OptiNose and Impel NeuroPharma.

How many acquisitions has Shin Nippon Biomedical Laboratories made?

Shin Nippon Biomedical Laboratories has made 1 acquisition, including Satsuma Pharmaceuticals.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available